Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study of the Safety and Efficacy of Daily CF101 Administered Orally, When Added to Weekly Methotrexate, in Patients With Active Rheumatoid Arthritis

NCT00280917 is registered in ClinicalTrials.gov with Can-Fite BioPharma as lead sponsor.

NCT NCT00280917
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00280917 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study of the Safety and Efficacy of Daily CF101 Administered Orally, When Added to Weekly Methotrexate, in Patients With Active Rheumatoid Arthritis
Lead sponsor
Can-Fite BioPharma
Phase
Phase 2
Overall status
Completed
Start date
June 30, 2006
Completion date
April 30, 2007
Enrollment
254 (actual)
Sites
35

Conditions

As the registry lists them; a condition with its own page is linked.

rheumatoid arthritis